Insulin Fused to Apolipoprotein A-I Reduces Body Weight and Steatosis in DB/DB Mice

Background: Targeting long-lasting insulins to the liver may improve metabolic alterations that are not corrected with current insulin replacement therapies. However, insulin is only able to promote lipogenesis but not to block gluconeogenesis in the insulin-resistant liver, exacerbating liver steat...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Pharmacol
Main Authors: Ardaiz, Nuria, Gomar, Celia, Vasquez, Marcos, Tenesaca, Shirley, Fernandez-Sendin, Myriam, Di Trani, Claudia Augusta, Belsué, Virginia, Escalada, Javier, Werner, Ulrich, Tennagels, Norbert, Berraondo, Pedro
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2021
Assuntos:
Pharmacology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7934061/
https://ncbi.nlm.nih.gov/pubmed/33679386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.591293
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares